TNBC is defined as breast cancer that lacks estrogen receptor, progesterone receptor expression and human epidermal growth factor receptor 2 (HER-2) over-expression or gene amplification, accounting for 10% ~ 15% of all breast cancer [1–3]. Here, ESR1 is linked to breast cancer.